Who
Steven Leonard Chapman
CEO and President
Company insider
Files Form 4 as: CEO and President, Natera.
In numbers
- Trades disclosed
- 955
- Buys
- 0
- Sells
- 181
- Bought
- $0
- Sold
- $309.1M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 11 Nov 2010
- Last trade
- 1 Oct 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 2 Oct 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $526K1,273 at $413.31 | filing |
| 1 Sep 2026filed 3 Sep 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $545K1,698 at $320.99 | filing |
| 1 Sep 2026filed 3 Sep 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $545K1,698 at $320.99 | filing |
| 3 Aug 2026filed 5 Aug 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $317K1,182 at $267.99 | filing |
| 3 Aug 2026filed 5 Aug 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $42K160 at $259.98 | filing |
| 3 Aug 2026filed 5 Aug 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $18K70 at $261.03 | filing |
| 3 Aug 2026filed 5 Aug 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $178K676 at $263.86 | filing |
| 3 Aug 2026filed 5 Aug 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $21K80 at $265.27 | filing |
| 3 Aug 2026filed 5 Aug 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $79K296 at $267.08 | filing |
| 3 Aug 2026filed 5 Aug 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $164K612 at $268.22 | filing |
| 3 Aug 2026filed 5 Aug 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $317K1,182 at $267.99 | filing |
| 3 Aug 2026filed 5 Aug 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $42K160 at $259.98 | filing |
| 3 Aug 2026filed 5 Aug 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $18K70 at $261.03 | filing |
| 3 Aug 2026filed 5 Aug 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $178K676 at $263.86 | filing |
| 3 Aug 2026filed 5 Aug 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $21K80 at $265.27 | filing |
| 3 Aug 2026filed 5 Aug 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $79K296 at $267.08 | filing |
| 3 Aug 2026filed 5 Aug 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $164K612 at $268.22 | filing |
| 28 Jul 2026filed 29 Jul 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $910K3,580 at $254.07 | filing |
| 28 Jul 2026filed 29 Jul 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $910K3,580 at $254.07 | filing |
| 27 Jul 2026filed 29 Jul 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $570K2,190 at $260.49 | filing |
The newest 500 lines are listed; the numbers count every line.
News
Natera (NASDAQ:NTRA) CEO Steven Leonard Chapman Sells 1,273 Shares of Company Stockdailypolitical.com · 6 Oct 2026Financial Comparison: Valneva (NASDAQ:VALN) and Natera (NASDAQ:NTRA)NTRA · tickerreport.com · 22 Oct 2026Natera (NTRA) Is Expanding Cancer Testing Rapidly. Does Its Valuation Leave Room for Error?NTRA · insidermonkey.com · 20 Oct 2026ESMO 2026 Presentations Deepen the Evidence Base for Natera's Oncology Portfolio and Leadership in Ultrasensitive MRD Technology | wallstreetONLINENTRA · wallstreet-online.de · 19 Oct 2026
1 headline in the last 90 days name Steven Leonard Chapman; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.